Clinical Trial Update: The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trial evaluating hydroxychloroquine for inflammatory cardiomyopathy and myocarditis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Cardiomyopathy
• Myocarditis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Tongji Hospital | Conditions: Inflammatory Cardiomyopathy, Myocarditis | Phase 2, Phase 3 | Status: RECRUITING